Brogan Inc.
pic-home
Decrease TextIncrease TextRestore Default
Brogan Inc.
Corporate

Formulary Updates

This page will be regularly updated with the latest provincial formulary updates in 2008.


Posted April 29, 2008
Nova Scotia
Nova Scotia Pharmacare Bulletin Vol #08-04, April 2008

Highlights
New Products: Medlance Plus Extra 200's 21G, 2.4mm, Medlance Plus Universal 200's 21G, 1.8mm, Medlance Plus Lite 200's 25G 1.5mm, sandoz lisinopril HCT 10mg/12.5mg, 20mg/12.5mg, 20mg/25mg tab; New Interchangeable Products: novo atenolthalidone 50mg&25mg tab, 100mg&25mg tab, apo bicalutamide 50mg tab, pms bisoprolol 5mg, 10mg tab, sandoz brimonidine 0.2% oph sol, sandoz cefprozil 112mg/5ml, 250mg/5ml o/l, sandoz cefprozil 250mg, 500mg tab, novo citalopram 40mg tab, pms clindamycin 150mg cap, 300mg cap, pms enalapril 2.5mg, 5mg, 10mg, 20mg tab, taro enalapril 2.5mg, 5mg, 10mg, 20mg tab, fenomax 160mg cap, co fluconazole 50mg, 100mg tab, pms gliclazide 80mg tab, pms ISMN SR 60mg SR tab, apo lisinopril/HCTZ 10mg&12.5mg tab, gen lisinopril/HCTZ 10mg&12.5mg tab, novo lisinopril/HCTZ (type p) 10mg&12.5mg tab, novo lisinopril/HCTZ (type z) 10mg&12.5mg tab, prinzide 10mg&12.5mg tab, zestoretic 10mg&12.5mg tab, pms minocycline 50mg, 100mg cap, novo morphine SR 60mg SR tab, gen pravastatin 10mg, 20mg, 40mg tab, ran rabeprazole 10mg, 20mg EC tab, co ramipril 1.25mg, 2.5mg, 5mg, 10mg cap, ramipril 2.5mg, 5mg, 10mg cap, ran tamsulosin 0.4mg SR cap, pms temazepam 15mg, 30mg cap, co venlafaxine XR 37.5mg, 75mg, 150mg XR cap, pms venlafaxine XR 37.5mg, 75mg, 150mg XR cap.



Posted April 29, 2008
Québec
Quebec Capsule, effective April 21, 2008

Highlights
Addition of Exception Medication: Isentress 400mg Tab



Posted April 22, 2008
Manitoba
Manitoba Bulletin #58, effective April 29, 2008

Highlights
Additions: Apo Clozapine 25mg, 100mg tab, Co Venlafaxine XR 37.5mg, 75mg, 150mg cap, CTP 30mg tab, Gen Atenolol 25mg tab, Gen Clozapine 50mg, 200mg tab, Gen Metoprolol (type L) 25mg tab, Novo morphine SR 60mg tab, pms Amiodarone 100mg tab, pms bisoprolol 5mg, 10mg tab, pms clindamycin 150mg, 300mg tab, pms doxycycline 100mg tab, 100mg cap, pms enalapril 2.5mg, 5mg, 10mg, 20mg tab, pms gliclazide 80mg tab, pms lisinopril 5mg, 10mg, 20mg tab, pms paroxetine 40mg tab, pms venlafaxine XR 37.5mg, 75mg, 150mg cap, ratio enalapril 2.5mg, 5mg, 10mg, 20mg tab, ratio lisinopril P 5mg, 10mg, 20mg tab, ratio lisinopril Z 5mg, 10mg, 20mg tab, ratio ramipril 1.25mg, 2.5mg, 5mg, 10mg cap, ratio tamsulosin 0.4mg cap, ratio venlafaxine XR 37.5mg, 75mg, 150mg cap, sandoz brimonidine 0.2% oph sol, sandoz enalapril 2.5mg, 5mg, 10mg, 20mg tab, sandoz lisinopril 5mg, 10mg, 20mg tab, sandoz lisinopril HCT 10/12.5mg, 20/12.5mg, 20/25mg tab, sandoz ramipril 1.25mg, 2.5mg, 5mg, 10mg cap, sandoz risperidone 0.25mg tab, sandoz tamsulosin 0.4mg cap, co fluconazole 50mg, 100mg tab, pms minocycline 50mg, 100mg cap, ran ciproflox 250mg, 500mg, 750mg tab, sandoz cefprozil 250mg, 500mg tab, sandoz cefprozil 125mg/5ml, 250mg/5ml susp, co pioglitazone 15mg, 30mg, 45mg tab, pms ISMN 60mg tab, pms levetiracetam 250mg, 500mg, 750mg tab, pms naproxen EC 375mg, 500mg tab, pms pioglitazone 15mg, 30mg, 45mg tab, ratio omeprazole 20mg tab, ratio pioglitazone 15mg, 30mg, 45mg tab, sandoz omperazole 20mg cap, sandoz pioglitazone 15mg, 30mg, 45mg tab, sutent 12.5mg, 25mg, 50mg cap, nexavar 200mg tab. New Interchangeable Products: 89, see bulletin for list. Interchangeable Product Price Changes: ratio oxycocet 5/325mg tab, ratio lenoltec No.2 300/15/15mg tab, ratio lenoltec No.3 300/15/30mg tab, ratio lenoltec No.4 300/60mg tab.



Posted April 17, 2008
Newfoundland
Newfoundland and Labrador Bulletin No 13 April 16, 2008

Highlights
92 additions - See bulletin for details.



Posted April 17, 2008
Newfoundland
Newfoundland and Labrador Bulletin No 12 April 15, 2008

Highlights
107 new interchangeable products - See buletin for details.



Posted April 15, 2008
Newfoundland
Newfoundland and Labrador Bulletin No 10 March 29, 2008

Highlights
The following DINs are Open Benefit to All Plans under NLPDP and Speacial Authorization for Cystics effective April 1, 2008: Apo Glimepiride 1mg, 2mg 4mg Tablet, Co Glimepiride 1mg, 2mg, 4mg Tablet, Novo Glimepiride 1mg, 2mg, 4mg Tablet, ratio Glimepiride 1mg, 2mg, 4mg Tablet, Sandoz Glimepiride 1mg, 2mg, 4mg Tablet

Back to Top  

Posted April 1, 2008
Alberta
Summary of Changes to the Alberta Health and Wellness Drug Benefit List - April 1, 2008

Highlights
New Drug Products Available by Special Authorization effective April 1, 2008: Baraclude 0.5mg tab, Hepsera 10mg tab; Additional Brands and/or Strengths of Drug Products Available by Special Authorization: Co Cabergoline 0.5mg tab, Pipercillin Sodium/Tazobactam Sodium 2g/vial (base) 250mg/vial base injection, Pipercillin Sodium/Tazobactam Sodium 3g/vial (base) 375mg/vial (base) injection, Pipercillin Sodium/Tazobactam Sodium 4g/vial (base) 500mg/vial (base) injection; Drug Products with Changes to Criteria for Coverage: Pegasys 180mcg/ml injection, Pegasys (0.5m; syringe) 180mgc/syr injection syringe; Discontinued Special Authorization Drug Products: Panoxyl 15 topical (alcohol) gel, Retin-A 0.01%, 0.025% topical cream, Vitamin A Acid 0.01%, 0.025%, 0.05%, 0.1% topical cream; Additional Brands and/or Strengths of Drug Products Available by Optional Special Authorization: Leavquin 750mg tab; Added Products: Apo Amoxi Clav 80mg/11.4ml oral susp, Apo Lisinopril/HCTZ 10mg/12.5mg tab, Aviane 21 tab, Avaine 28 tab, Ciprodex 0.3%/0.1% otic susp, Co Ramipril 1.25mg, 2.5mg, 5mg, 10mg cap, CTP 30mg tab, Hyzaar 100mg/12.5mg tab, Novo Citalopram 20mg tab, Novo Enalapril 2.5mg, 5mg, 10mg, 20mg tab, Novo Enalapril/HCTZ 5mg/12.5mg, 10mg/25mg tab, Novo Rabeprazole 10mg, 20mg enteric coated tab, Pms ISMN 60mg ER tab, Pms Venlafaxine XR 37.5mg, 75mg, 150mg ER tab, Sandoz Omeprazole 10mg, 20mg SR cap, Taro Enalapril 2.5mg, 5mg, 10mg, 20mg tab; Change in Status from Special Authorization to Unrestricted: Losec 10mg SR tab; Deleted Products: 56 products listed. See list for details.



Posted April 1, 2008
Saskatchewan
Formulary & EDS Updates Bulletin # 114

Highlights
Effective April 1, 2008 the following products will be listed as benefits: gen Atenolol 25mg Tab, sandoz Brimonidine 0.2% oph sol, Sandoz Cefprozil 25mg/ml, 50mg/ml o/susp, mint Citalopram 20mg, 40mg Tab, pms Clindamycin 150mg, 300mg Cap, Aviane 21 & Aviane 28 0.02mg/0.1mg tab, pms ISMN 60mg Tab, gen Metoprolol 25mg tab, pms Minocycline 50mg, 100mg Cap, novo Morphine SR 60mg, 100mg, 200mg tab ER, apo pantoprazole 40mg tab, ran pantoprazole 40mg tab, apo timop gel 0.5mg oph gel sol; Exception Drug Status Criteria Effective April 1, 2008: Sandoz Cefprozil 25mg/ml, 50mg/ml o/susp, pms Minocycline 50mg, 100mg cap, apo Pantoprazole 40mg tab, ran Pantoprazole 40mg tab; Effective April 1, 2008 the EDS Criteria has been approved for a new indication: Humira 40mg/0.8ml pre filled syringe; Effective April 1, 2008the EDS Criteria for the following products have been revised as indicated: Axert 6.25mg, 12.5mg tab, Amerge 1mg, 2.5mg tab, Maxalt 5mg, 10mg tab, Maxalt 5mg, 10mg wafer, Imitrex25mg, 50mg, 100mg tab, Imitrex 6mg/0.5ml inj sol, Imitrex 5mg, 20mg nasal spray, Zomig 2.5mg tab, Zomig 2.5mg o/dis tab, DDAVP-FEI 10mcg/dose, apo Desmopressin 10mcg/dose, Ketek 400mg tab; Price Changes: Suprax 400mg tab, Losec 20mg tab/cap, apo omeprazole 20mg tab/cap.



Posted March 26, 2008
British Columbia
BC Pharmacare Newsletter Edition 08-003

Highlights
Extended Coverage of Drug Treatments for Chronic Hepatitis B effective March 27, 2008: Extended PharmaCare Special Authority coverage for Heptovir and Intron A, New Special Authority coverage for Hepsera and Baraclude

Back to Top  

Posted March 31, 2008
Ontario
ODB Update 11, effective April 9 2008

Highlights
New Multi Source Drugs: Co Venlafaxine 37.5mg, 75mg, 150mg Cap ER, Novo Morphine SR 60mg, 100mg, 200mg Tab ER, pms Clindamycin 300mg Cap, pms Propafenone 150mg, 300mg Tab, ran Pantoprazole 40mg Ent Tab, Sandoz Rampril 1.25mg, 2.5mg, 5mg, 10mg Tab; Manufacturer Requested Discontinued Drug(s): Kwellada-P 1% Cr Rinse, Kwellada-P 5% Lot, Nix Dermal Cream 5% Cr, Panoxyl 15% Gel, R&C Shampoo/Conditioner 0.3% & 3% & 1.2% Top Sol, Trasicor 40mg Tab; New Diabetic Testing Agents: Ascensia Breeze 2 Strip; Not-A-Benefit Drug(s): apo Amoxi Clav 400mg & 57mg/ml Susp, gen Domperidone 10mg Tab; Off Formulary Interchangeable Products: gen Metformin 850mg Tab, pms Metformin 850mg Tab, pms Minocycline 50mg, 100mg Cap, ran Metformin 850mg Tab; Drug Benefit Price(s): 325 See List for Details



Posted March 31, 2008
Saskatchewan
Saskatchewan Bulletin #114, April 2008

Highlights
New Full Formulary Interchangeable Listings: gen Atenol 25mg Tab, Aviane 21 & Aviane 28 0.02mg/0.1mg Tab, gen Metoprolol 25mg Tab; Revised Exception Drug Status (EDS) Criteria: New Safety Information: apo Desmopressin intranasal solution, Health Canada Alert: Ketek 400mg Tab. Axert 6.25mg, 12.5mg Tab, Amerge 1mg, 2.5mg Tab, Maxalt 5mg, 10mg Tab, Maxalt 5mg, 10mg wafer, Imitrex 25mg, 50mg 100mg Tab, Imitrex 6mg/0.5ml inj sol, imitrex 5mg, 20mg nasal spray, Zomig 2.5mg Tab, Zomig 2.5mg o/dis Tab; Exception Drug Status (EDS) Drugs Approved for a New Indication: Humira 40mg/0.8ml pre filled syringe; Products Not Recommended by the Saskatchewan Review Committees: Cyestra 0.035mg/2mg Tab (21 Tab), Elaprase 2mg/ml inj sol, Thelin 100mg Tab, Fosrenol 250mg, 500mg, 750mg, 1000mg Tab, Spriafil 40mg/ml o/susp, Mezavant 1.2g ER Tab, CTP-30 30mg Tab; New Interchangeable Listings Effective April 1, 2008: Sandoz Brimonidine 0.2% oph sol, mint Citalopram 20mg, 40mg Tab, pms Clindamycin 150mg, 300mg Tab, pms ISMN 60mg Tab, novo Morphine SR 60mg, 100mg, 200mg ER Tab, apo Timop 0.5% oph gel; 2008 According to Current EDS Criteria: Sandoz Cefprozil 25mg/ml, 50mg/ml o/susp, pms Minocycline 50mg, 100mg Cap, apo pantoprazole 40mg Tab, ran Pantoprazole 40mg Tab



Posted March 31, 2008
New Brunswick
Benefit Changes to NBPDP, Bulletin 711, March 27, 2008

Highlights
Regular Benefit Additions: Linessa 21 & Linessa 28 100/125/150/25mcg Tab, Rebif Initiation Pack 8.8mcg/0.2ml & 22mcg/0.5ml INJ-SC SOL, Altace 15mg Cap; No longer requires Special Authorization: Lamictal Chewtabs 2mg, 5mg Tab Chew, Lamictal 25mg, 100mg, 150mg Tab, apo Lamotrigine 25mg, 100mg, 150mg Tab, gen Lamotrigine 25mg, 100mg, 150mg Tab, novo Lamotrigine 25mg, 100mg, 150mg Tab, pms Lamotrigine 25mg, 100mg, 150mg Tab, ratio Lamotrigine 25mg, 100mg, 150mg Tab; Special Authorization Addisions: Hepsera 10mg Tab, Ciprodex 0.3%/0.1% otic susp, Duragesic 12mcg/h transdermal patch, Pegasys 180mcg/1ml vial & 180mcg/1ml prefilled syringe; Drugs Reviewed and Not Listed: Sativex 27mg/ml/ 25mg/ml buccal spray, Trusopt 2% preservative free oph sol, Cosopt 2%/0.5% preservative free oph sol, Pegasys 180mcg/1ml vial & 180mcg/1ml prefilled syringe, Sebivo 600mg Tab, Zytram XL 150mg, 200mg, 300mg, 400mg controlled release Tab.

Back to Top  

Posted March 28, 2008
Newfoundland
Newfoundland Bulletin No 8, correction to Bulletin #6

Highlights
Delisted from the NIDPF and as a benefit of NLPDP effective March 26, 2008 not delisted as a benefit of NLPDP effective April 1, 2008 as indictaed in Bulletin #6: Ratio-Fluticasone 50mcg/metered Dose Nasal Spray.



Posted March 28, 2008
Newfoundland
Newfoundland Bulletin No 7 , effective March 26, 2008

Highlights
Delisted from the NIDPF effective March 26, 2008: ratio-Fluticasone Aqueous Spray, Flonase Aqueous Spray



Posted March 28, 2008
Newfoundland
Newfoundland Bulletin No 6, March 12, 2008

Highlights
NLPDP Product Deletion: Ratio-Flicasone 50mcg/metered dose nasal spray



Posted March 25, 2008
British Columbia
BC Pharmacare Newsletter Edition 08-002, Mar 20, 2008

Highlights
Now Available as Limited Coverage Drugs through the PharmaCare Special Authority Program: Adalimumab 40mg/0.8ml Inj; Etanercept 25mg/vial, 50mg/ml Inj; Infliximab 100mg/vial IV.



Posted March 25, 2008
New Brunswick
Formulary Product Updates, Vol 49, Update No.#3 Mar 4, 2008

Highlights
Addition to New Brunswick Formulary: Gen-Atenolol 25mg Tab; Novo-Atenolthalidone 50mg/25mg, 100mg/25mg Tab; Apo-Bialutamide 50mg Tab; Gen-Biclutamide 50mg Tab; pms-Bisoprolol 5mg, 10mg Tab; Novo-Citalopram 40mg Tab; pms-Clindamycin 150mg, 300mg Cap; Vaseretic 5mg/12.5mg, 10mg/25mg Tab; Novo-Enalapril/HCTZ 5mg/12.5mg, 10mg/25mg Tab; Co-Fluconazole 50mg, 100mg Tab; pms-Gliclazide 80mg Tab; pms-ISMN 60mg Tab; Prinzide 10mg/12.5mg, 20mg/12.5mg, 20mg/25mg Tab; Zestoretic 10mg/12.5mg, 20mg/12.5mg, 20mg/25mg Tab; Novo-Lisinopril HCTZ (Type P) 10mg/12.5mg, 20mg/12.5mg, 20mg/25mg Tab; Novo-Lisinopril (Type Z) 10mg/12.5mg, 20mg/12.5mg, 20mg/25mg Tab; Apo-Metoprolol 25mg Tab; Gen-Metoprolol (Type L) 25mg Tab; pms-Minocycline 50mg, 100mg Cap; Co-Pioglitazone 15mg, 30mg, 45mg Tab; pms-Pioglitazone 15mg, 30mg, 45mg Tab; Co-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; pms-Temazepam 15mg, 30mg Cap; pms-Venlafaxine XR 37.5mg, 75mg, 150mg Cap. New Interchangeables: Novo-Enalapril/HCTZ 5mg/12.5mg, 10mg/25mg Tab; Apo-Metoprolol 25mg Tab; Gen-Metoprolol (Type L) 25mg Tab.



Posted March 25, 2008
New Brunswick
Benefit Changes to NBPDP, Bulletin #710, Mar 4, 2008

Highlights
NBPDP Benefit Additions: Gen-Atenolol 25mg Tab; Novo-Atenolthalidone 50mg/25mg, 100mg/25mg Tab; Apo-Bialutamide 50mg Tab; Gen-Biclutamide 50mg Tab; pms-Bisoprolol 5mg, 10mg Tab; Novo-Citalopram 40mg Tab; pms-Clindamycin 150mg Cap; Novo-Enalapril/HCTZ 5mg/12.5mg, 10mg/25mg Tab; Co-Fluconazole 50mg, 100mg Tab; pms-Gliclazide 80mg Tab; pms-ISMN 60mg Tab; Novo-Lisinopril HCTZ (Type P) 10mg/12.5mg, 20mg/12.5mg, 20mg/25mg Tab; Novo-Lisinopril (Type Z) 10mg/12.5mg, 20mg/12.5mg, 20mg/25mg Tab; Gen-Metoprolol (Type L) 25mg Tab; pms-Minocycline 50mg, 100mg Cap; Co-Pioglitazone 15mg, 30mg, 45mg Tab; pms-Pioglitazone 15mg, 30mg, 45mg Tab; Co-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; pms-Temazepam 15mg, 30mg Cap; pms-Venlafaxine XR 37.5mg, 75mg, 150mg Cap. Non-Listed Products Subject to Map: pms-Clindamycin 300mg Cap.

Back to Top  

Posted March 20, 2008
Nova Scotia
NS Pharmacare Bulletin Vol #08-03, March 2008

Highlights
New Pharmacare Reimbursement Levels effective March 15, 2008: ratio Oxycocet 5mg Tab, Life Brand Portable System (50), Life Brand Test Strips 50, 100; Change in Criteria: Zyprexa Zydis; New Products: Cuprimine 205mg Cap, pms Amiodarone 100mg Tab, pms Hydrochlorothiazide 12.5mg Tab, pms Paroxtine 40mg Tab, Reyataz 300mg Cap; New Diabetic Products: FreeStyle Lite Test Strips 50/box, 100/box; Additions to Exception Status for Selected Anti Tumor Necrosis Factor (TNF) Agents: Remicade, Humira, Enbrel



Posted March 20, 2008
Ontario
ODB Update 10 - Second Amendment, effective Mar 25, 2008

Highlights
Not a Benefit Drug: Apo-Perindopril 8mg Tab



Posted March 19, 2008
Ontario
ODB Update 10 - Amended, effective Mar 25, 2008

Highlights
Not a Benefit Drugs: Sandoz-Diclofenac SR 75mg, 100mg LA Tab



Posted March 13, 2008
Ontario
ODB Update 10, effective Mar 25, 2008

Highlights
New Single Source Drug(s): Lucentis 10mg/ml Inj Sol-0.3mL Vial Pk; New Multi Source Drug(s): Ceftriaxone Sodium for Injection 1g/vial, Gen Bicalutamide 50mg, Octreotide Acetate Omega 50mcg/ml, 100mcg/ml, 200mcg/ml Inj Sol- 1ml Amp Pk, Octreotide Acetate Omega 500mcg/mL Inj Sol- 5mL Vial pk, Pms Temazepam 15mg, 30mg Cap, Ran Ciproflox 250mg, 500mg, 750mg Tab, Sandoz Cefprozil 250mg, 500mg Tab, Sandoz Diclofenac SR 75mg, 100mg LA Tab; Manufacturer Requested Discontinued Drugs: Gen Clomipramine 10mg, 25mg, 50mg Tab, Gen Diltiazem 30mg, 60mg Tab, Peg Lyte Sol- 1L pk, Pms Cholestyramine Oral Pd 42 Dose Pk, Pms Cholestyramine (sugar free) Oral Pd 42 Dose Pk, Pms Ketoprofen E-50 50mg Ent Tab, Pms Loxapine 25mg/ml O/L, Pms Oxtriphylline 10mg/ml O/L, PMS Temazepam 15mg, 30mg Cap, PMS Theophylline 5.3mg/ml O/L; Price Change- Drug Benefit Price: Ratio-Oxycocet 5mg, 325mg Tab; New Manufacturer Name: Resultz 50% Top Sol 120ml Pk, Resultz 50% Top Sol 240ml Pk; Off Formulary Interchangeable Products: Apo Alpraz 1mg Tab, Apo Alpraz TS 2mg Tab, Gen Alprazolam 1mg, 2mg Tab, Pms Pamidronate 3mg/ml, 9mg/ml Inj Sol- 10ml Vial; Discontinued Drugs Removed from Payment and Listing: Megacillin 500 500000IU Tab, Pms Cimetidine 200mg, 300mg, 400mg, 600mg, 800mg Tab, PMS Dexamethasone 0.1% Oph/Ot Sol, Pms Gentamicin 0.3% Oph Sol, Pms Ketoprofen 50mg Cap, Pms Ketoprofen E-100 100mg Ent Tab, Pms Metoprolol-B 50mg, 100mg Tab, Pms Misoprostol 200mcg Tab, Pms Nifedipine 5mg, 10mg Cap, Pms Piroxicam 10mg, 20mg Cap, Pms Piroxicam 10mg Sup, Pms Tiaprofenic 200mg Tab, Pms Trihexyphenidyl 0.4mg/ml O/L



Posted March 10, 2008
Prince Edward Island
PEI Formulary Update Issue 08-01, Mar 3, 2008

Highlights
Additions to the Drug Programs Formulary effective immediately: 59 listed. See Update for details. Status Change to Full Benefit: 46 listed. See Update for details. Changes to Criteria: 115 listed. See Update for details.



Posted March 10, 2008
Quebec
Modification no 1, correction no4, effective Feb 22, 2008

Highlights
Additions: Apo-Pioglitazone 15mg, 30mg, 45mg Tab; Co Pioglitazone 15mg, 30mg, 45mg Tab; Gen-Pioglitazone 15mg, 30mg, 45mg Tab, Novo-Pioglitazone 15mg, 30mg, 45mg Tab; pms_Pioglitazone 15mg, 30mg, 45mg Tab; ratio-Pioglitazone 15mg, 30mg, 45mg Tab; Sandoz Pioglitazone 15mg, 30mg, 45mg Tab. Price changes: 49 products affected - see update for details. Discontinued at request of manufacturer: Novo-Ramipril 1.25mg Cap or Tab

Back to Top  

Posted March 3, 2008
Manitoba
Manitoba Drug Benefits and Interchangeability Formulary Amendments, Bulletin #57 effective Mar 19, 2008

Highlights
Additions: 126 new additions- See List for Details; New Interchangeable Categories: 102 new interchangeable categories- See List for Details; New Interchangeable Products: 55 new interchangeable products- See List for Details; Product Deletions: 55 product deletions- See List for Details; Category Changes: Novo Mirtazapine OD 15mg, 30mg, 45mg Tab; Interchangeable Product Price Changes: 62 interchangeable product price changes- See List for Details; Discontinued Products: 50 discontinued products- See List for Details



Posted February 20, 2008
Saskatchewan
Saskatchewan Bulletin #113, February 2008

Highlights
New Formulary Listing: Life Brand Blood Glucose Monitoring Test Strips- HOM, Losartan potassium/HCTZ 100mg/12.5mg Tab (Hyzaar MSD); Exception Drug Status- Drugs Approved for New Indication: Adalimumab pre filled syringe 40mg/0.8ml (Humira ABB), Etanercept powder for injection (vial) 25mg/vial; pre filled syringe, 50mg/ml (Enbrel- AMG); New Exception Drug Status: Adefovir dipivoxil 10mg Tab (Hepsera-GSI), Alglucosidase alfa, powder for solution, 50mg/vial (Myozyme-GZY), Ciprofloxacin HCl/dexamethasone, otic suspension, 0.3%/0.1% (Ciprodex-ALC), Entecavir 0.5mg Tab (Baraclude-BMY); New Strength/Dosage Forms: Adalimumab, pre filled syringe 40mg/0.8ml (Humira Pen- ABB), Darbepoetin alfa 500ug/ml pre filled syringe (Aranesp-AMG), Desmopressin 50ug, 120ug Tab (DDAVP Melt-FEI), Risedronate sodium 75mg Tab (Actonel-PGA); Revised EDS Criteria: Insulin Aspart, injection for solution, 100U/ml (5x3ml), 10ml , Novo Rapid-NOO, Insulin Lispro, injection for solution 100U/ml 5x1.5ml, 5x3ml Humalog- LIL, Levofloxacin 250mg, 500mg Tab (Levaquin-JAN); Under Review with the National Common Drug Review: Aclasta (osteoporosis), Adderall XR, Atripla, Invega, Isentress, Januvia, Lucentis, Ralivia, Rasilez, Tridural, Zeldox; Under Review by the Saskatchewan Review Committees: Sativex, Raptiva, Enbrel, Remicade; Products not Recommended for Coverage via the Common Drug Review Process: Natalizumab 300mg/ml inj sol (tysabri-BGN), Delta-9-Tetrahydrocannabinol and cannabidiol 27mg/ml & 25mg/ml buccal spray, Tramadol Hydrochloride 150mg, 200mg, 300mg, 400mg Tab (Zytram-XL-PFR), Telbivudine 600mg Tab (Sebivo-NVR), Varenicline 0.5mg, 1mg Tab (Champix-PFI); Products not Recommended by the Saskatchewan Review Committees: Infliximab 100mg/vial injection (Remicade-SCH), Amiodarone 100mg Tab (Pms Amiodarone-PMS), Paroxetine HCl 40mg Tab (pms-Paroxetine- PMS), Methylphenidate HCl 80mg Cap (Biphentin PFR), Testosterone 1% gel for transdermal application (Testim-PAL); New Interchangeable Listings effective 11/01/2007: Citalopram hydrobromide 20mg Tab (novo Citalopram- NOP), Enalapril 2.5mg, 5mg, 10mg, 20mg Tab (Apo Enalapril- APX) (Co Enalapril- COB), (Gen Enalapril-GPM), (Novo Enalapril- NOP), (Pms Enalapril-PMS), (Ratio Enalapril-RPH), (Sandoz Enalapril-SDZ), Ethinyl Estradiol/1-Norgestrel 0.03mg/0.15mg Tab (21 tablet) (28 tablet) (Portia-APX), Lisinopril 5mg, 10mg, 20mg Tab (Apo Lisinopril- APX), (Co Lisinopril-COB), (Gen Lisinopril- GPM), Novo Lisinopril-NOP), (pms-Lisinopril-PMS), (Ran-Lisinopril-RAN), (Ratio Lisinopril-RAN), (Sandoz-Lisinopril-SDZ), Lisinopril/Hydrochlorothiazide 10mg/12.5mg Tab (Apo Lisinopril/HCTZ-APX), Ramipril 1.25mg, 2.5mg, 5mg, 10mg Tab (Sandoz Ramipril-SDZ) 1.25mg, 2.5mg, 5mg, 10mg Cap (Co Ramipril-COB), Tamsulosin HCl 0.4mg SR Cao (Ran Tamsulosin-RAN), Venlafaxune HCl 37.5mg, 75mg, 150mg Cap (Pms Venlafaxine XR-PMS); New Interchangeable EDS Listings effective 11/01/2007: Amoxicillin trihydrate/potassium clavulanate 80mg/11.4mg/ml oral suspension (Apo Amoxi Clav- APX), Omeprazole 10mg, 20mg Cap (Sandoz Omeprazole-SDZ); New Interchangeable Listings effective 12/01/2007: Enalapril 2.5mg, 5mg, 10mg, 20mg Tab (Taro Enalapril-TAR), Lisinopril/HCTZ 10mh/12.5mg Tab (Gen Listinopril/HCTZ-GPM), (Novo Listinopril/HCTZ-NOP), Sandoz Listinopril/HCTZ-SDZ), Listinopril/HCTZ 20mg/12.5mg Tab, (Apo Listinopril/HCTZ-APX), (Gen Listinopril/HCTZ- GPM), Novo Listinopril/HCTZ-NOP), (Sandoz Listinopril/HCTZ-SDZ), Listinopril/HCTZ 20mg/25mg Tab, (Apo Listinopril/HCTZ-APX), (Gen Listinopril/HCTZ-GPM), (Novo Listinopril/HCTZ-NOP), Sandoz Listinopril/HCTZ-SDZ); New Interchangeable EDS Listings effective 12/01/2007: Cabergoline 0.5mg Tab (Co Cabergoline-COB), Omeprazole 20mg Cap (Losec-AST), Rabeprazole Sodium 10mg, 20mg Tab (Novo Rabeprazole-NOP), (Ran Rabeprazole-RAN); New Interchangeable EDS Listings effective 02/15/2008: Atenol/chlorthalidone 50mg/25mg, 100mg/25mg Tab (Novo Atenolthalidone-NOP), Citalopram hydrobromide 40mg Tab (Novo-Citalopram-NOP), Htdromorphone HCl 3mg sup (Pms Hydromorphone-PMS), Temazepam 15mg, 30mg Cap (Pms Temazepam-PMS); New Interchangeable EDS Listings effective 02/15/2008: Bisprolol fumarate 50mg, 10mg Tab (Pms Bisoprolol-PMS), Cefprozil 250mg, 500mg Tab (Sandoz Cefprozil-SDZ), Piogliazone 15mg, 30mg, 45mg Tab (Gen Piogliazone-GPM), Apo Piogliazone-APX), (Co Piogliazone-COB), (Novo Piogliazone-NOP), (Ratio Piogliazone-RPH), (Sandoz Piogliazone-SDZ), (Pms Piogliazone-PMS); Product(s) withdrawn from the Market by Health Canada: Pergolide mesylate 0505mg, 0.25mg, 1mg Tab (Permax-RBP).



Posted February 20, 2008
British Columbia
BC Pharmacare Newsletter Edition 08-001, Feb 18, 2008

Highlights
Extension of Coverage Period for Plavix; New Drugs Categorized to LCA and/or RDP: Co Rampril 10mg, 5mg, 2.5mg, 1.25mg Cap, Co Topiramate 200mg, 100mg, 25mg Tab, Pms Clarithromycin 500mg, 250mg Tab, Pms Digoxin 0.0625mg Tab, Pms Venlafaxine XR 150mg, 75mg, 37.5mg Caps, Ratio Venlafaxine 150mg, 75mg, 37.5mg Caps, Pms Fluconazole 150mg Caps; New Drugs Categorized to LCA by Exception: Pms Paroxetine (Paroxetine) 40mg Tab; Benefits: Alvesco (Ciclesonide) 100mcg, 200mcg inhaled dose, Duotrav (Travoprost and Timolol Maleate) 0.004%/0.5% ophthalmic solution, Pms Amiodarine 100mcg Tab, Hypertonic Saline Compound Solution, Sodium Chloride 14.6 mg/ml injection, Sodium Chloride for injection 23.4%, Sterile water for injection; Limited Coverage Program: Nutropin (Somatropin) 5mg/vial, 10mg/vial, Nutropin AQ (Somatropin) 10mg/2ml vial, Nutropin AQ Pen (Somatropin) 10mg/2ml cartridge; Non Benefits: Apo Glimepiride 4,g, 2mg, 1mg Tab, Nutropin (Somatropin) 5mg/vial, 10mg/vial, Nutropin AQ (Somatropin) 10mg/2ml vial, Nutropin AQ Pen (Somatropin) 10mg/2ml cartridge; Submission Withdrawn: Actonel Plus Calcium 35mg-500mg Tab



Posted February 12, 2008
Newfoundland
Behind the Scenes - Winter 2007

Highlights
Newfoundland and Labrador Prescription Drug Program Changes; Newfoundland and Labrador Interchangeable Formulary: New Categories Effective January 1, 2008 to Interchangeable Formulary: Benazepril Hydrochloride 5mg and 10mg Tabs, Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, and 15mg Tabs, Cefprozil 250mg and 500mg Tabs, Cefprozil 125mg/5ml and 250mg/5ml suspension, Levonorgestrel/Ethinyl Estradiol 0.15mg/0.03mg Tabs, Fluticasone Propionate 50mcg/metered dose spray, Enalapril Maleate 2.5mg, 5mg, 10mg, and 20mg Tabs, Sumatriptan 25mg, 50mg and 100mg Tabs; Changes to the NLPDP Benefit Listing: New open benefits for D-Forte Capsules, Cortimyxin Opthalmic Ointment; Special Authorization: Sprycel 20mg,50mg, 70mg for CML, Novo-Enoxaparin, Pegasys 180ug injection for Hepatitis C; New Special Authorization Pre Approval Coverage: Norvasc 5mg and 10mg; The following special authorization medications have new coverage criteria: Femara 2.5mg for Breast Cancer, Arimidex 1mg for Breast Cancer, Aromasin 25mg for Breast Cancer, Carvediol 3.125mg, 6.25mg, 12.5mg, and 25mg for stable symptomatic heart failure, VFend 50mg and 200mg for culture proven invasive candidiasis.



Posted February 12, 2008
New Brunswick
Benefit Changes to NBPDP, Bulletin #708, Feb 11, 2008

Highlights
Regular Benefit Additions: ASA ECT 81mg Tab, Equate Daily Low Dose EC 81mg Tab, Exact Coated Daily Low Dose ASA 81mg Tab, Rexall Coated Daily Low Dose ASA 81mg Tab; Special Authorization Additions: Dasatinib (Sprycel) 20mg, 50mg, 70mg Tabs, Sorafenib (Nexavar) 200mg Tabs- resubmission, Suniyinib (Sutent) 12.5mg, 25mg, and 50mg Caps- resubmission

Back to Top  

Posted February 11, 2008
NIHB
Updates to Drug Benefit List - Winter 2007/2008

Highlights
Additions to the Drug Benefit List- New Open Benefits- Single Source Drug Products - AccuChek Compact Plus Glucometer, Ascensia Breeze 2 Test Strip, DDAVP Melt 120MCG, 240MCG, 60MCG Tab, Reservoir 5xx 1.8ml syringe, Reservoir 7xx 3.0ml syringe, Resultz 50% Solution, Somatulin Autogel 60mg/0.3ml, 90mg/0.3ml and 120mg/0.3ml; Multi-Source Drug Products: 108 Products Added- See list for details; New Limited Use Benefits: Single-Source Drug Products: Orencia 250mg/15ml injection, Ciprodex OTIC Suspension, Campix 0.5mg Tabs, Champix 1mg Tabs, Champix Starter Pack; Limited Use Benefits- Multi-Source Products: Ran-Tamsulosin 0.4mg SR Caps; Not added to Formulary: Apo Glimepiride 1mg, 2mg, 4mg Tabs, Gen-Zopiclone 5mg Tab, Preg Vit Folic 5, Remicade 100mg/vial injection; Changes in Benefit Staus from Open Benefit to Limited Use: Foradil 12mcg Caps for Inhalation, Oxeze 12mcg/inhalation Turbuhaler, Oxeze 6mcg/inhalation Turbuhaler, Serevent 50mcg/inhalation Diskhaler, Serevent 50mcg/inhalation Diskus; Drugs Discontinued by the Manufacturer: Dimetapp Oral Infant Drop, Duralith 10mg Tab, Endodan 5mg/325mg Tab, Fluotic 20mg Tab, Intal Inhaler, Largactil 40mg/ml injection, Nozinan 5mg, 25mg, 50mg Tab, Orifer F Tab, Premarin 0.9mg Tab, Prexige 100mg Tab, Ratio Aclavulanate 250mg & 125mg Tab, Ratio Aclavulanate 25mg & 6.25mg/ml suspension, Ratio Aclavulanate 50mg & 12.5mg/ml suspension, Ratio Desipramine 25mg and 50mg Tab, Ratio Ipratropium 250 mcg/ml solution, Rhotrimine 75mg caps, Rhotrimine 100mg Tabs, Stemetil 5mg/ml injection, Surgam 300mg SR Caps, Triphasil 21 and 28 Tabs



Posted February 11, 2008
Prince Edward Island
Memorandum: re New MAC List, Feb 4, 2008

Highlights
New Interchangeable/MAC Categories: Ethinyl Estradiol & Cyproterone 0.035mg & 2mg Tab; Products Added to the Interchangeable/MAC List: Apo-Bicalutamide 50mg Tab, Gen-Bicalutamide 50mg Tab, Pms-Temazepam 15mg, 30mg Caps; Discontinued Products: Endodan 5mg Tab, Flomax 0.4mg Controlled Release Cap, Gen-Clomipramine 10mg, 25mg, 50mg Tab, Gen-Diltiazem 30mg, 60mg Tab, Novo-Ramipril 1.25mg Cap, Pms-Alendronate 70mg Tab, Pms- Temazepam 15mg, 30mg Cap



Posted February 11, 2008
Alberta
Additions to AHWDBL, Feb 1, 2008

Highlights
New Drug Products Added to the AHWDBL: New Interchangeable Products Affected by LCA Pricing: Pioglitazone Hydrochloride: Apo-Pioglitazone 15mg, 30mg, 45mg Tab, Ratio-Pioglitazone 15mg, 30mg, 45mg Tab, Sandoz Pioglitazone 15mg, 30mg, 45mg Tab, Raberprazole Sodium: Ran Rabeprazole 10mg, 20mg Oral Enteric Coated Tab



Posted February 11, 2008
Nova Scotia
NS Pharmacare Bulletin Vol #08-02, Feb 2008

Highlights
Changes in Criteria for Clopidogrel (Plavix); Correction to the Criteria for Efalizumab(Raptiva) published in the December Pharmacists Bulletin Vol. #07-11; New Products: Advicor 40/1000 mg Tab, Aricept RDT 5mg Tab, Aricept RDT 10mg Tab, Baraclude 0.5mg Tab, Diovan 320 mg Tab, Humira 40mg/0.8mL Syringe Inj, Humira 40mg/0.8mL Pen, Myozyme 50mg Pdr for Inj, Nexavar 200mg Tab, Novo Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab, Sebivo 600mg Tab, Sutent 12.5mg, 25mg, 50mg Cap; Changes in Criteria for Bosentan(Tracleer) and Sildenafil(Revatio); New Diabetic Products: Life Brand Blood Glucose Testing System, Life Brand Blood Glucose Test Strips 50/box, 100/box; New MAC Category: Olanzapine Tablets, 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tabs; Removal of Mac Category: Apo-Misoprostol 100mg Tab, Novo-Misoprostol 100mg Tab; Discontinued Products; 80 See list for details.

Back to Top  

Posted February 7, 2008
Ontario
ODB Edition #40, Update 9, effective Feb 12, 2008

Highlights
New Single Source Drugs: Diovan 320mg Tab; Resultz 50% Top Sol 120ml, 240ml; Tri-Cyclen Lo 3 Phase Tab 21Pk, 28Pk. New Multi-Source Drugs: Novo-Atenolthalidone 50 & 25mg, 100 & 25mg Tab; PMS-Bisoprolol 5mg, 10mg Tab; PMS-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; PMS-Pioglitazone 15mg, 30mg, 45mg Tab. Manufacturer Requested Discontinued Drugs: Novo-Misoprostol 100mcg Tab; Nozinan 25mg/ml Inj Sol 1ml Pk. Delisted Drug: Novo-Ramipril 1.25mg Cap. Price Changes: 37 in total - see bulletin for details. Discontinued Drugs: Endodan 5mg & 325mg Tab; Fucidin Leo Suspension 49.2mg/ml Orl Susp; Pondocillin 35mg/ml O/L. Off Formulary Interchangeable: Apo-Fluoxetine 10mg Cap; Apo-Gemfibrozil 600mg Tab; Gen-Fluoxetine 10mg Cap; Gen-Gemfibrozil 600mg Tab; Novo-Fluoxetine 10mg Cap; Novo-Gemfibrozil 600mg Tab; PMS-Diclofenac K 50mg Tab; PMS-Fluoxetine 10mg Cap; PMS-Gemfibrozil 600mg Tab; PMS-Terbinafine 250mg Tab; Ratio-Fluoxetine 10mg Cap; Sandoz Fluoxetine 10mg Cap.



Posted January 23, 2008
New Brunswick
Benefit Changes to NBPDP, Bulletin #705, Jan 22, 2008

Highlights
Special Authorization Additions: Adalimumab 40mg/ml Prefilled syringe, Prefilled pen; Darbepoetin 10mcg, 20mcg, 30mcg, 40mcg, 50mcg, 60mcg, 80mcg, 100mcg, 130mcg, 150mcg, 200mcg, 300mcg, 500mcg Singleject Prefilled syringe; Efalizumab 150mg Vial; Epoetin Alfa 1000iu/0.5ml, 2000iu/0.5ml, 3000iu/0.3ml, 4000iu/0.4ml, 5000iu/0.5ml, 6000iu/0.6ml, 8000iu/0.8ml, 10000iu/ml, 20000iu/ml, 40000iu/ml Vial, Prefilled syringe; Lanreotide Acetate 60mg, 90mg, 120mg Prefilled syringe. Special Authorization Revised Criteria: Bosentan 62.5mg, 125mg Tab. Drugs Reviewed and Not Listed: Bupropion 150mg, 300mg Tab ER; Lumiracoxib 100mg Tab; Varenicline 0.5mg, 1mg Tab.



Posted January 22, 2008
Nova Scotia
NS Pharmacare Bulletin Vol #08-01, January 2008

Highlights
New Pharmacare Reimbursement List effective February 14, 2008: Discontinued: Acetylsalcylic Acid 325mg & Oxycodone 5mg Tab -Endodan, Amoxicillin & Enzyme Inhibitor 250mg Tab- Clavulin & ratio-Aclavulanate, Ceftriaxone 2g/vial Inj- Rocephin, Desonide 0.05% Crm- Desocort, Imipramine 25mg Tab- Tofranil, Ketoconazole 2% Crm- Nizoral, Lithium 300mg SR Tab, Duralith, Oxybutynin 1mg/ml O/L- Ditropan; Manufacturer Shortage of Lowest Priced Brand: Azithromycin Pos 100mg Tab- Zithromax, Clonidine 0.025mg Tab- Dixarit, Enalapril 10mg & HCTZ 25mg Tab- Vaseretic; New Special MAC Categories: Ketoprofen 50mg Cap, Ketoprofen 50mg, 100mg EC Tab, Ketoprofen 200mg SR Cap, Naproxen 125mg Tab, Meloxicam 7.5mg Tab, Ondansetron 4mg Tab; Increased to Selected MAC: Amoxicillin 250mg, 500mg Cap, Amoxicillin 25mg/ml, 50mg/ml O/L, Cefaclor 500mg Tab, Cephalexin Monohydrate 250mg, 500mg Tab, Cloxacillin 250mg, 500mg Cap, Cloxacillin 25mg/ml O/L, Penicillin V Potassium 300mg Tab, Penicillin V Potassium 60mg/ml O/L.

Back to Top  

Posted January 17, 2008
Ontario
Edition 40, Update 8A Jan 16, 2008

Highlights
Not a Benefit Drugs: Apo-Cefaclor 375mg/5ml Oral Susp; Gen-Amoxicillin 250mg cap, 500mg cap; Novo-Cefaclor 250mg, 500mg Cap; Novo-Lexin 250mg, 500mg Tab. Status change from Not a Benefit to General Benefit: Apo-Cefaclor 250mg, 500mg Cap; Apo-Cephalex 350mg, 500mg Tab; Novamoxin 250mg, 500mg Cap. Price changes: 20 in total - see bulletin for details



Posted January 9, 2008
Prince Edward Island
PEI Memorandum, New MAC List

Highlights
New Interchangeable/MAC Categories: Atenolol & Chlorthalidone 25mg and 50mg Tab, Atenolol & Chlorthalidone 25mg and 100mg Tab, Ethinyl Estradiol & L-Norgestrel 0.02mg and 0.10mg Tab (21day), Ethinyl Estradiol & L-Norgestrel 0.02mg and 0.10mg Tab (28day), Pioglitazone 15mg, 30mg and 45mg Tab; Products Added to the Interchangeable/MAC List: Co Fluconazole 50mg and 100mg Tab, Gen Atenolol 25mg Tab, Gen Metoprolol (type L) 25mg Tab, Pms Bisoprolol 5mg and 10mg Tab, Pms Ismn 60mg Tab; Discontinued Products: Dexasone 0.5mg Tab, Oxybutyn 5mg Tab, Sandoz Risperidone 0.25mg Tab



Posted January 9, 2008
Newfoundland
Newfoundland Labrador Bulletin: Notice re Volume 53 pricing

Highlights
Please note that the mandatory charging of the lowest price (per the price posted in the Volume 53 edition of the Formulary) for the following new categories will come into effect January 15, 2008: New Categories: Apo-Benazepril 5mg, 10mg Tab, Lotensin 5mg, 10mg Tab, Novo-Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab, Zyprexa 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab, Ran-Cefprozil 250mg, 500mg Tab, Apo-Cefprozil 250mg, 500mg Tab, Cefzil 250mg, 500mg Tab, Apo-Cefprozil125mg/5ml, 250mg/ml oral susp, Ran-Cefprozil 250mg/ml oral susp, Cefzil 125mg/ml, 250mg/ml oral susp, Portia 21 0.15mg/ 0.03ml, Portia 28 0.15mg/0.03ml, Min-Ovral 21 0.15mg/0.03ml, Min-Ovral 28 0.15mg/0.03ml Tabs, ratio-Fluticasone 50mcg/metered dose Aqueous Spray, Flonase 50mcg/metered dose Aqueous Spray, Apo-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab, Vasotec 2.5mg, 5mg, 10mg, 20mg Tab, Novo-Sumatriptan DF 25mg, 50mg, 100mg Tab, Gen-Sumatriptan 25mg, 50mg, 100mg Tab, Imitrex DF 25mg, 50mg, 100mg Tab; Additions to Existing Categories: Gen-Zopiclone 5mg Tab, Gen-Ondansetron 4mg, 8mg Tab, Gen-Tamsulosin 0.4mg Cap, Sandoz Tamsulosin 0.4mg Cap, Co Topiramate 25mg, 100mg, 200mg Tab, Ran-Pravastatin 10mg, 20mg, 40mg Tab, ratio-Venlafaxine XR 37.5mg, 75mg, 150mg Cap, Sandoz Ramipril 1.25mg, 2.5mg, 5mg, 10mg Tab, Co Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap, pms-Levetiracetam 250mg, 500mg, 750mg Tab, Apo-Glimepiride 1mg, 2mg, 4mg Tab, Novo-Fenofibrate-S 100mg, 160mg Tab, Apo-Brimonidine 0.2% oph sol, Novo-Citalopram 20mg Tab, pms-ASA EC 325mg Tab; As per the prior notice regarding Volume 53 of the Formulary, please note that for this Volume only the prices of Volume 52, for those products listed in Volume 52, remain in effect until Jan 31st, 2008. New prices reflected in Volume 53, for products that were in Volume 52, comes into effect Feb 1st, 2008



Posted January 9, 2008
Alberta
Quarterly Updates to AHWDBL & AEIIDBS, effective Jan 1, 2008

Highlights
Drug Additions: Pms-Amiodarone HCL 100mg Tab; Apo-Desmopressin 0.1mg, 0.2mg Tab; Novo-Desmopressin 0.1mg, 0.2mg Tab; Apo-Doxy 100mg Tab, Cap; Doxycin 100mg Tab, Cap; Novo-Doxylin 100mg Tab, Cap; Pms-Doxycycline 100mg Tab, Cap; Co Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Gen-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Ratio-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Sandoz Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Apo-Hydro 25mg, 50mg Tab; Portia 21 150mcg & 30mcg Tab; Portia 28 150mcg & 30mcg Tab; Co-Lisinopril 5mg, 10mg, 20mg Tab; Gen-Lisinopril 5mg, 10mg, 20mg Tab; Novo-Lisinopril (Type P) 5mg, 10mg, 20mg Tab; Novo-Lisinopril (Type Z) 5mg, 10mg, 20mg Tab;Ran-Lisinopril 5mg, 10mg, 20mg Tab; Ratio-Lisinopril P 5mg, 10mg, 20mg Tab; Ratio-Lisinopril Z 5mg, 10mg, 20mg Tab; Sandoz Lisinopril 5mg, 10mg, 20mg Tab; Apo-Metoprolol SR 100mg SR Tab, 200mg SR Tab; Gen-Ondansetron 4mg, 8mg Tab; Novo-Ondansetron 4mg, 8mg Tab; Pms-Ondansetron 4mg, 8mg Tab; Ratio-Ondansetron 8mg Tab; Sandoz Ondansetron 4mg, 8mg Tab; Pms-Paroxetine 40mg Tab; Apo-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; Novo-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; Ratio-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; Sandoz Ramipril 1.25mg, 2.5mg, 5mg, 10mg Tab; Gen-Tamsulosin 0.4mg SR Cap; Novo-Tamsulosin 0.4mg SR Cap; Ran-Tamsulosin 0.4mg SR Tab; Ratio-Tamsulosin 0.4mg SR Tab; Sandoz Tamsulosin 0.4mg SR Tab; Co Topiramate 25mg, 100mg, 200mg Tab; Gen-Topiramate 25mg, 100mg, 200mg Tab; Novo-Topiramate 25mg, 100mg, 200mg Tab; Pms-Topiramate 25mg, 100mg, 200mg Tab; Ratio-Topiramate 25mg, 100mg, 200mg Tab; Sandoz Topiramate 25mg, 100mg, 200mg Tab; Apo-Zopiclone 5mg Tab; Co Zopiclone 5mg Tab; Gen -Zopiclone 5mg Tab; Novo-Zopiclone 5mg Tab; Pms-Zopiclone 5mg Tab; Ran-Zopiclone 5mg Tab; Ratio-Zopiclone 5mg Tab; Sandoz Zopiclone 5mg Tab; Special Authorization: Exjade 125mg, 250mg, 500mg Tab; Eprex 20,000U/Syr Inj; Fentanyl Citrate 0.05mg/ml Inj; Somatuline Autogel 60mg/Syr, 90mg/Syr, 120mg/Syr Inj; Apo-Levetiracetam 250mg, 500mg, 750mg Tab; Co-Levetiracetam 250mg, 500mg, 750mg Tab; Pms-Levetiracetam 250mg, 500mg, 750mg Tab; Pegasys 180mcg/ml Inj; Pegasys 180mcg/Syr Inj; Jevity 1.5 Cal Liq; Discontinued Listings: Desocort 0.05% Top Cream; Dexasone 0.5mg Tab; Endantadine 100mg Cap; Endodan Tab; Formulex 10mg Cap; Norpramin 25mg, 50mg Tab; Novo-Hylazin 25mg Tab; Nozinan 5mg, 25mg, 50mg Tab; Ostoforte 50,000 IU Cap; Oxybutyn 5mg Tab; Pms-Tiaprofenic 300mg Tab; Ratio-Aclavulanate 250mg/125mg Tab; Ratio-Desipramine HCL 25mg, 50mg Tab; Ratio-Ipratropium 0.25mg/ml Inh Sol; Tofranil 25mg, 75mg Tab; Triphasil 21day, 28 day Tab

Back to Top  

Posted January 9, 2008
Ontario
ODB Edition #40, Update 8, effective Jan 15, 2008

Highlights
New Multi-Source Drugs: Apo-Bicalutamide 50mg Tab; Apo-Lisinopril/HCTZ 20mg & 12.5mg Tab; Apo-Pioglitazone 15mg, 30mg, 45mg Tab; Aviane 21 20mcg & 100mcg Tab-21 Pk; Aviane 28 20mcg & 100mcg Tab-28 Pk; Ceftriaxone 1g/Vial, 2g/Vial inj; Co Fluconazole 50mg, 100mg Tab; Co Pioglitazone 15mg, 30mg, 45mg Tab; Gen-Lisinopril HCTZ 10mg & 12.5mg, 20mg & 12.5mg Tab; Gen-Pioglitazone 15mg, 30mg, 45mg Tab; Novo-Citalopram 40mg Tab; Novo-Lisinopril/HCTZ (Type P0 10mg & 12.5mg, 20mg & 12.5mg Tab; Novo-Lisinopril/HCTZ (Type Z) 10mg & 12.5mg, 20mg & 12.5mg Tab; Novo-Pioglitazone 15mg, 30mg, 45mg Tab; Novo-Rabeprazole EC 10mg, 20mg Tab; Ran-Rabeprazole 10mg, 20mg Tab; Ratio-Pioglitazone 15mg, 30mg, 45mg Tab; Sandoz-Lisinopril HCT 10mg & 12.5mg, 20mg & 12.5mg Tab; Sandoz Pioglitazone 15mg, 30mg, 45mg Tab; Taro-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Manufacturer Requested Discontinued Drugs: Combivent 20mcg/100mcg/md Aero Inh; Novo-Citalopram 40mg Tab; Ostoforte 50000iu Cap; Oxybutyn 5mg Tab; Pancrease 4500 & 20000 & 25000 usp SR Cap; Timoptic 0.25% Oph Sol; 127 Drug Benefit Price Changes; Not-A-Benefit Drugs: Apo-Erythro E-C 250mg Ent Pel Cap; NU-Amoxi 250mg, 500mg Cap, 25mg/ml, 50mg/ml O/L; Nu-Cefaclor 250mg, 500mg Cap; Nu-Cephalex 250mg, 500mg Tab; Nu-Cloxi 250mg, 500mg Cap, 25mg/ml O/L; Nu-Pen VK 300mg Tab; Off Formulary Interchangeable Products: Apo-Acyclovir 200mg, 400mg Tab; Apo-Diclo Rapide 50mg Tab; Apo-Feno-Micro 67mg Cap; Apo-Methylephenidate 20mg Tab; Apo-Minocycline 50mg, 100mg Cap; Apo-Naproxen EC 250mg, 375mg, 500mg Ent Tab; Apo-Trimebutine 100mg, 200mg Tab; Gen-Acyclovir 200mg, 400mg Tab; Gen-Minocycline 50mg, 100mg Cap; Gen-Naproxen EC 250mg, 375mg, 500mg Ent Tab; Novo-Acyclovir 200mg, 400mg Tab; Novo-Difenac-K 50mg Tab; PMS-Deferoxamine 500mg/Vial, 2g/vial Inj; PMS-Methylphenidate 20mg Tab; PMS-Naproxen EC 375mg, 500mg Ent Tab; Ratio-Acyclovir 200mg, 400mg Tab; Ratio-Minocycline 50mg, 100mg Cap; Sandoz Diclofenac Rapide 50mg Tab; Sandoz Minocycline 50mg, 100mg Cap; Status Changes from Not-A-Benefit to General Benefit: Portia 21 0.03mg & 0.15mg Tab-21 Pk; Portia 28 0.03mg & 0.15mg Tab-28 Pk.



Posted January 2, 2008
Manitoba
Manitoba Interchangeable Formulary Jan 2, 2008

Highlights
Full Interchangeable Formulary Release.



Posted January 2, 2008
Manitoba
Manitoba Drug Benefits and Interchangeability Formulary Amendments, Bulletin #56 effective Jan 2, 2008

Highlights
Deletions from FB: Mirapex 0.25mg, 0.5mg, 1mg, 1.5mg Tab; Novo-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg Tab; pms-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg Tab. Additions to RB: Mirapex 0.25mg, 0.5mg, 1mg, 1.5mg Tab; Novo-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg Tab; pms-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg Tab. Not Recommended: Azilect 0.5mg, 1mg Tab; Cipralex 10mg, 20mg Tab; Denavir 1% cream; Tramacet 37.5mg/325mg Tab; Tysabri 300mg/15ml Inj; Vantas 50mg Inj; Vesicare 5mg, 10mg Tab; Androgel 2.5g, 5g gel. Interchangeable Product Price Changes: Agrylin 0.5mg Cap; Amatine 2.5mg, 5mg Tab; Amaryl 1mg, 2mg, 4mg Tab; Anuzinc 10mg Supp; Apo-Amoxi 250mg, 500mg Cap, 125mg/5ml, 250mg/5ml Susp; Apo-Cefaclor 250mg, 50mg Cap, 125mg/5ml, 250mg/5ml Susp; Apo-Cephalex 250mg, 500mg Tab; Apo-Cloxi 250mg, 500mg Cap, 125mg/5ml Susp; Apo-Pen VK 300mg Tab, 300mg/5ml Susp; Apo-Triazolam 0.125mg, 0.25mg Tab; Apo-Zidovudine 100mg Cap; Arava 10mg, 20mg Tab; Buspar 10mg Tab; Carbolith 100mg Cap; Celexa 20mg, 40mg Tab; Coumadin 1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg, 10mg Tab; Diabeta 2.5mg, 5mg Tab; Famvir 125mg, 250mg, 500mg Tab; Fosamax 5mg, 10mg, 40mg, 70mg Tab; Gen-Amoxicillin 250mg, 500mg Cap; Gen-Sotalol 80mg Tab; Gen-Triazolam 0.125mg, 0.25mg Tab; Glucophage 500mg, 850mg Tab; Imovane 5mg, 7.5mg Tab; Keppra 250mg, 500mg, 750mg Tab; Lasix 20mg, 40mg Tab; Lioresal 10mg, 20mg Tab; Lopressor 50mg, 100mg Tab; Lotensin 20mg Tab; Miacalcin 0.2mcg Nasal Spray; Monopril 10mg,20mg Tab; Myochrysine 10mg/ml, 50mg/ml Amp; Nitrazadon 5mg, 10mg Tab; Nitrolingual 0.4mg Pumpspray; Novamoxin 250mg, 500mg Cap, 125mg/5ml, 250mg/5ml Susp; Novamoxin(low sucrose) 125mg/5ml, 250mg/5ml Susp; Novo-Cloxin 250mg, 500mg Cap, 125mg/5ml Susp; Novo-Ferrousgluc 300mg Tab; Novo-Hydrazide 25mg, 50mg Tab; Novo-Cefaclor 500mg Cap; Novo-Lexin 250mg, 500mgTab, 125mg/5ml Susp; Novo-Pen VK 300mg Tab, 300mg/5ml Susp; Novo-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg Tab; Nu-Amoxi 250mg, 500mg Cap, 125mg/5ml, 250mg/5ml Susp; Nu-Cefaclor 500mg Cap; Nu-Cephalexin 250mg, 500mg Tab; Nu-Cloxi 250mg, 500mg Cap, 125mg/5ml Susp; Nu-Pen VK 300mg Tab; Plaquenil 200mg Tab; pms-Amoxicillin 250mg, 500mg Cap, 125mg/5ml, 250mg/5ml Susp; pms-Bisacodyl 10mg Supp; pms-Cephalexin 250mg Tab, 125mg/5ml, 250mg/5ml Susp; Pravachol 10mg, 40mg Tab; Renedil 2.5mg, 5mg, 10mg Tab; Rifadin 10mg, 300mg Cap; Ritalin 10mg, 20mg Tab; Ritalin SR 20mg Tab; Sandoz Anuzinc 0.5% Oint; Sectral 100mg, 200mg, 400mg Tab; Sofracort Oph/Ot Drops; Surgam 300mg Tab; Tegretol 200mg Tab, 100mg, 200mg Chew Tab, 200mg, 400mg CR Tab; Timoptic 0.5% Oph Drops; Tofranil 25mg, 50mg Tab; Trandate 100mg Tab; Trental 400mg Tab; Visken 5mg, 10mg, 15mg Tab; Voltaren 50mg, 100mg Supp, 50mg Tab; Voltaren Rapide 50mg Tab; Voltaren SR 75mg, 100mg SR Tab; Zanaflex 4mg Tab; Zantac 150mg, 300mg Tab; Zorcor 5mg, 10mg, 20mg, 40mg, 80mg Tab.

Back to Top  

Sub Menu
Overview
Current News
Formulary Updates
PMPRB News - Regulations
Archives
Login
Corporate
Expertise
Products
Seminars
Publications
News
Careers



Subscribe to our mailing list:

Subscription Form

Copyright